BC Innovations | Feb 11, 2016
Targets & Mechanisms

Complementary ideas

A Harvard team has mapped one of the strongest, and most difficult to decipher, genetic risk factors for schizophrenia to C4a, a molecule involved in the complement cascade. While the results offer a new therapeutic...
BioCentury | May 4, 2009
Emerging Company Profile

InflaRX: Safety in Sepsis

Xigris drotrecogin alfa is the only drug approved to treat sepsis, but a narrow label and bleeding risks have limited its use to severely septic patients at high risk of death. InflaRx GmbH believes its...
Items per page:
1 - 2 of 2